[Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy].
Beteiligte Einrichtungen
Abstract
While the activity of tyrosine kinase inhibitors as the first line treatment for primary tumors in patients with stage IV non-small cell lung cancer and a positive EGF receptor mutation is well known, little data on the efficacy in controlling cerebral metastases are available.
Bibliografische Daten
| Originalsprache | Deutsch |
|---|---|
| Aufsatznummer | 12 |
| ISSN | 0179-7158 |
| Status | Veröffentlicht - 2011 |
| pubmed | 22127359 |
|---|
